AFFINITY FOR THE DOPAMINE-D2 RECEPTOR PREDICTS NEUROLEPTIC POTENCY IN BLOCKING THE REINFORCING EFFECT OF MFB STIMULATION

被引：74
|
作者：
GALLISTEL, CR
DAVIS, AJ
机构：
来源：
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 1983年 / 19卷 / 05期
关键词：
D O I：
10.1016/0091-3057(83)90095-3
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：867 / 872
页数：6
相关论文
共 50 条
  • [31] THE DOPAMINE-D2 RECEPTOR LOCUS AS A MODIFYING GENE IN NEUROPSYCHIATRIC DISORDERS
    COMINGS, DE
    COMINGS, BG
    MUHLEMAN, D
    DIETZ, G
    SHAHBAHRAMI, B
    TAST, D
    KNELL, E
    KOCSIS, P
    BAUMGARTEN, R
    KOVACS, BW
    LEVY, DL
    SMITH, M
    BORISON, RL
    EVANS, DD
    KLEIN, DN
    MACMURRAY, J
    TOSK, JM
    SVERD, J
    GYSIN, R
    FLANAGAN, SD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (13): : 1793 - 1800
  • [32] THE DOPAMINE-D2 RECEPTOR IS EXPRESSED IN GH3 CELLS
    JOHNSTON, JM
    WOOD, DF
    BOLAJI, EA
    JOHNSTON, DG
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1991, 7 (02) : 131 - 136
  • [33] EFFECTS OF DOPAMINE-D1 AND DOPAMINE-D2 RECEPTOR ANTAGONISTS ON ORAL ACTIVITY IN RATS
    LEVIN, ED
    SEE, RE
    SOUTH, D
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (01) : 43 - 48
  • [34] EFFECT OF THE DOPAMINE-D2 RECEPTOR AGONIST QUINPIROLE ON THE INVIVO RELEASE OF DOPAMINE IN THE CAUDATE-NUCLEUS OF HYPERTENSIVE RATS
    LINTHORST, ACE
    DELANG, H
    DEJONG, W
    VERSTEEG, DHG
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 201 (2-3) : 125 - 133
  • [35] PIVOTAL ROLE FOR ASPARTATE-80 IN THE REGULATION OF DOPAMINE-D2 RECEPTOR AFFINITY FOR DRUGS AND INHIBITION OF ADENYLYL CYCLASE
    NEVE, KA
    COX, BA
    HENNINGSEN, RA
    SPANOYANNIS, A
    NEVE, RL
    MOLECULAR PHARMACOLOGY, 1991, 39 (06) : 733 - 739
  • [36] PARTIAL-PURIFICATION OF DOPAMINE-D2 RECEPTORS USING LECTIN AFFINITY COLUMNS
    ABBOTT, WM
    STRANGE, PG
    BIOSCIENCE REPORTS, 1985, 5 (04) : 303 - 308
  • [37] DOPAMINE-D2 RECEPTOR STIMULATION INHIBITS INOSITOL PHOSPHATE GENERATING-SYSTEM IN RAT STRIATAL SLICES
    PIZZI, M
    DAPRADA, M
    VALERIO, A
    MEMO, M
    SPANO, PF
    HAEFELY, WE
    BRAIN RESEARCH, 1988, 456 (02) : 235 - 240
  • [38] SITE-DIRECTED MUTAGENESIS OF THE HUMAN DOPAMINE-D2 RECEPTOR
    MANSOUR, A
    MENG, F
    MEADORWOODRUFF, JH
    TAYLOR, LP
    CIVELLI, O
    AKIL, H
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (02): : 205 - 214
  • [39] DOPAMINE D2 RECEPTOR BLOCKING EFFECT OF IMIPRAMINE IN THE RAT HIPPOCAMPUS
    SMIALOWSKI, A
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 39 (01) : 105 - 108
  • [40] NMDA RECEPTOR ANTAGONISTS INHIBIT CATALEPSY INDUCED BY EITHER DOPAMINE-D1 OR DOPAMINE-D2 RECEPTOR ANTAGONISTS
    MOORE, NA
    BLACKMAN, A
    AWERE, S
    LEANDER, JD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 237 (01) : 1 - 7
12345